Agenus, Inc. (AGEN)
6.94
+0.05
(+0.73%)
USD |
NASDAQ |
Sep 11, 16:00
6.94
0.00 (0.00%)
After-Hours: 20:00
Agenus Market Cap : 295.75M for Sept. 11, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 11, 2026 | 295.75M |
| September 10, 2026 | 293.62M |
| September 09, 2026 | 292.34M |
| September 08, 2026 | 316.63M |
| September 04, 2026 | 351.15M |
| September 03, 2026 | 351.15M |
| September 02, 2026 | 344.76M |
| September 01, 2026 | 340.50M |
| August 31, 2026 | 324.30M |
| August 28, 2026 | 326.44M |
| August 27, 2026 | 332.83M |
| August 26, 2026 | 351.58M |
| August 25, 2026 | 356.27M |
| August 24, 2026 | 326.86M |
| August 21, 2026 | 344.76M |
| August 20, 2026 | 319.19M |
| August 19, 2026 | 352.00M |
| August 18, 2026 | 320.90M |
| August 17, 2026 | 304.70M |
| August 14, 2026 | 311.95M |
| August 13, 2026 | 298.31M |
| August 12, 2026 | 294.05M |
| August 11, 2026 | 291.06M |
| August 10, 2026 | 298.31M |
| August 07, 2026 | 296.60M |
| Date | Value |
|---|---|
| August 06, 2026 | 319.19M |
| August 05, 2026 | 331.55M |
| August 04, 2026 | 319.73M |
| August 03, 2026 | 301.24M |
| July 31, 2026 | 288.91M |
| July 30, 2026 | 304.71M |
| July 29, 2026 | 255.40M |
| July 28, 2026 | 254.24M |
| July 27, 2026 | 236.14M |
| July 24, 2026 | 230.36M |
| July 23, 2026 | 238.45M |
| July 22, 2026 | 213.03M |
| July 21, 2026 | 214.95M |
| July 20, 2026 | 191.45M |
| July 17, 2026 | 192.99M |
| July 16, 2026 | 192.61M |
| July 15, 2026 | 192.99M |
| July 14, 2026 | 195.69M |
| July 13, 2026 | 235.75M |
| July 10, 2026 | 129.05M |
| July 09, 2026 | 124.81M |
| July 08, 2026 | 125.20M |
| July 07, 2026 | 134.83M |
| July 06, 2026 | 131.36M |
| July 02, 2026 | 134.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Novavax, Inc. | 1.553B |
| Amgen, Inc. | 204.00B |
| Anika Therapeutics, Inc. | 279.17M |
| BioCryst Pharmaceuticals, Inc. | 2.073B |
| Imunon, Inc. | 6.859M |
Market Cap Related Metrics
| PE Ratio | 2.618 |
| PS Ratio | 1.932 |
| Price | 6.94 |
| Earnings Yield | 38.20% |
| Operating PE Ratio | 7.147 |
| Normalized PE Ratio | 6.952 |